Dawnrays Pharmaceutical Holdings Ltd.(HK:2348)
HK$0.90-0.01 (-1.10%)
HK:2348
Dawnrays Pharmaceutical Holdings Ltd. financials statements
HK$0.90
At close:-0.01 (-1.10%)
Want to see HK:2348 full AI Analyst Report?
Dawnrays Pharmaceutical Holdings Ltd. (2348) Financial Statements
6 Followers
Dawnrays Pharmaceutical Holdings Ltd. Financial Overview
Dawnrays Pharmaceutical Holdings Ltd.'s market cap is currently ¥1.36B. The company's EPS TTM is ¥0.15; its P/E ratio is 5.01; and it has a dividend yield of 7.00%. Dawnrays Pharmaceutical Holdings Ltd. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | ¥ 1.23B | ¥ 1.06B | ¥ 1.15B | ¥ 1.28B | ¥ 1.17B |
| Gross Profit | ¥ 557.40M | ¥ 577.63M | ¥ 641.52M | ¥ 766.68M | ¥ 675.36M |
| Operating Income | ¥ 229.65M | ¥ 367.91M | ¥ 277.42M | ¥ 422.41M | ¥ 380.76M |
| EBITDA | ¥ 347.57M | ¥ 308.67M | ¥ 498.94M | ¥ 505.19M | ¥ 438.31M |
| Net Income | ¥ 213.97M | ¥ 564.94M | ¥ 326.00M | ¥ 358.06M | ¥ 358.18M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | ¥ 1.58B | ¥ 1.37B | ¥ 1.07B | ¥ 993.04M | ¥ 830.22M |
| Total Assets | ¥ 4.01B | ¥ 4.01B | ¥ 3.62B | ¥ 3.67B | ¥ 3.34B |
| Total Debt | ¥ 77.51M | ¥ 34.72M | ¥ 120.53M | ¥ 8.41M | ¥ 23.52M |
| Net Debt | ¥ -1.09B | ¥ -1.12B | ¥ -785.30M | ¥ -803.27M | ¥ -554.22M |
| Total Liabilities | ¥ 621.75M | ¥ 682.61M | ¥ 763.42M | ¥ 1.02B | ¥ 941.70M |
| Stockholders' Equity | ¥ 3.39B | ¥ 3.32B | ¥ 2.85B | ¥ 2.64B | ¥ 2.38B |
| Cash Flow | |||||
| Free Cash Flow | ¥ 236.01M | ¥ 44.58M | ¥ 126.39M | ¥ 229.90M | ¥ 80.07M |
| Operating Cash Flow | ¥ 355.41M | ¥ 220.20M | ¥ 338.40M | ¥ 434.27M | ¥ 393.14M |
| Investing Cash Flow | ¥ -368.80M | ¥ 205.17M | ¥ -387.57M | ¥ -175.01M | ¥ -284.20M |
| Financing Cash Flow | ¥ -54.99M | ¥ -189.44M | ¥ 2.07M | ¥ -92.70M | ¥ -129.75M |
Currency in CNY
